Viridian Therapeutics, Inc.
VRDNNASDAQHealthcare● Active
$15.73
$-0.05(-0.32%)
Market Cap$1.4B
P/E Ratio—
52W High$34.29
52W Low$13.18
Viridian Therapeutics, Inc. (VRDN) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · VRDN · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $874.65M | $717.58M | $477.37M | $424.55M | $196.97M |
| Net Receivables | $0.00M | $0.00M | $0.10M | $0.10M | $0.45M |
| Inventory | $0.00M | $0.00M | $0.00M | ($6.62M) | $0.00M |
| Total Current Assets | $894.23M | $738.46M | $486.48M | $424.55M | $200.16M |
| PP&E Net | $3.65M | $3.44M | $3.34M | $2.94M | $2.06M |
| Goodwill | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Intangible Assets | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Assets | $899.42M | $742.40M | $490.42M | $435.09M | $203.71M |
| Liabilities | |||||
| Short-Term Debt | $0.75M | $0.00M | $0.00M | $0.00M | $0.00M |
| Accounts Payable | $8.68M | $2.14M | $2.24M | $14.23M | $2.33M |
| Total Current Liabilities | $70.70M | $47.87M | $26.64M | $33.35M | $13.64M |
| Long-Term Debt | $49.94M | $20.58M | $20.20M | $4.64M | $0.00M |
| Total Liabilities | $177.25M | $70.76M | $48.40M | $40.03M | $15.99M |
| Stockholders Equity | |||||
| Retained Earnings | ($1338.46M) | ($995.86M) | ($725.91M) | ($488.17M) | ($358.30M) |
| Total Stockholders Equity | $722.17M | $671.64M | $442.02M | $395.06M | $187.72M |
| Total Liab & Equity(computed) | $899.42M | $742.40M | $490.42M | $435.09M | $203.71M |
| Debt Summary | |||||
| Total Debt | $50.69M | $21.09M | $21.05M | $5.26M | $0.52M |
| Net Debt | ($161.69M) | ($78.50M) | ($81.78M) | ($150.32M) | ($41.78M) |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M
Explore more Viridian Therapeutics, Inc. data
About Viridian Therapeutics, Inc. (VRDN) Balance Sheet
Viridian Therapeutics, Inc. (VRDN) balance sheet shows total assets of $0.90B with cash of $0.87B. Total liabilities are $0.18B, total debt $0.05B, and stockholders equity $0.72B.
Frequently asked questions
VRDN · 4 questionsViridian Therapeutics, Inc. has total debt of $0.05B with net debt of ($0.16B).
VRDN total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10